Table 2 Clinical and biochemical characteristics of the study subjects according to quartiles of TG/HDL

n

4522

4533

4466

4535

Age (years)

37.5 ± 10.3

39.4 ± 10.4

41.8 ± 10.4

45.5 ± 10.0

<  0.001

Male/Female

2123/2399

2107/2426

2098/2368

2115/2420

0.957

BMI (kg/m²)

21.5 ± 2.6

22.5 ± 2.9

23.5 ± 3.2

24.9 ± 3.1

<  0.001

SBP (mmHg)

112.6 ± 13.9

115.3 ± 15.0

118.4 ± 15.9

124.7 ± 16.6

<  0.001

DBP (mmHg)

74.4 ± 9.7

76.0 ± 10.3

78.1 ± 10.5

81.7 ± 10.3

<  0.001

FPG (mM)

5.1 ± 0.6

5.2 ± 0.9

5.4 ± 1.0

5.6 ± 1.3

<  0.001

TG (mM)

0.7 (0.6–0.9)

1.0 (0.8–1.3)

1.4 (1.1–1.9)

2.5 (1.8–3.5)

<  0.001

TC (mM)

4.5 (4.0–5.0)

4.6 (4.1–5.2)

4.8 (4.2–5.4)

5.1 (4.5–5.8)

<  0.001

LDL-C (mM)

2.5 ± 0.6

2.7 ± 0.7

2.9 ± 0.7

3.0 ± 0.8

<  0.001

HDL-C (mM)

1.8 ± 0.4

1.5 ± 0.3

1.3 ± 0.3

1.1 ± 0.2

<  0.001

ALT (IU/L)

9 (7–13)

10 (7–14)

11 (8–17)

13 (10–21)

<  0.001

AST (IU/L)

20 (18–24)

20 (17–24)

21 (18–25)

22 (19–28)

<  0.001

Scr (μM)

69.9 ± 14.9

72.5 ± 15.4

74.6 ± 15.6

78.7 ± 20.2

<  0.001

SUA (μM)

296.0 ± 77.4

311.8 ± 83.7

328.3 ± 89.1

357.7 ± 92.5

<  0.001